Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-21

Clinical Trial Update: Dose Frequency RCT on DTTC in Children With CAS [NA]

View source ↗

Summary

Clinical trial entry describing an RCT evaluating dose frequency of Dynamic Temporal and Tactile Cueing (DTTC) therapy for Childhood Apraxia of Speech in childr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DTTC therapy (Dynamic Temporal and Tactile Cueing)

Snippet

Sponsor: Marquette University | Conditions: Childhood Apraxia of Speech | NA | Status: ACTIVE_NOT_RECRUITING